Amplifon S.p.A.
General ticker "AMFPF" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $5.1B (TTM average)
Amplifon S.p.A. does not follow the US Stock Market performance with the rate: -24.6%.
Estimated limits based on current volatility of 0.0%: low 16.49$, high 16.49$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-20, amount 0.33$ (Y2.00%)
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [18.42$, 30.51$]
- 2025-12-31 to 2026-12-31 estimated range: [16.75$, 28.10$]
Financial Metrics affecting the AMFPF estimates:
- Positive: with PPE of 31.0 at the end of fiscal year the price was neutral
- Positive: 7.61 < Operating profit margin, % of 10.66
- Positive: 6.66 < Operating cash flow per share per price, % of 8.00
- Positive: Industry inventory ratio change (median), % of -0.52 <= -0.18
- Negative: Industry operating profit margin (median), % of 0.74 <= 2.99
- Negative: Investing cash flow per share per price, % of -5.94 <= -4.43
- Positive: Interest expense per share per price, % of 1.02 <= 3.31
- Negative: -0.75 < Inventory ratio change, % of -0.04
- Positive: 1.84 < Return on assets ratio (scaled to [-100,100]) of 3.52
Short-term AMFPF quotes
Long-term AMFPF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €2,119.13MM | €2,260.08MM | €2,409.24MM |
| Operating Expenses | €1,843.42MM | €2,000.87MM | €2,152.43MM |
| Operating Income | €275.71MM | €259.21MM | €256.81MM |
| Non-Operating Income | €-32.28MM | €-49.47MM | €-60.03MM |
| Interest Expense | €32.84MM | €44.62MM | €57.76MM |
| Income(Loss) | €243.43MM | €209.75MM | €196.78MM |
| Taxes | €64.96MM | €54.72MM | €51.21MM |
| Profit(Loss)* | €178.53MM | €155.14MM | €145.37MM |
| Stockholders Equity | €1,038.51MM | €1,100.92MM | €1,150.00MM |
| Inventory | €76.26MM | €88.32MM | €93.18MM |
| Assets | €3,575.47MM | €3,693.22MM | €3,992.76MM |
| Operating Cash Flow | €458.62MM | €413.54MM | €451.16MM |
| Capital expenditure | €115.63MM | €141.65MM | €146.42MM |
| Investing Cash Flow | €-194.39MM | €-261.48MM | €-335.10MM |
| Financing Cash Flow | €-353.19MM | €-135.06MM | €-18.85MM |
| Earnings Per Share** | €0.80 | €0.69 | €0.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.